Trustmark Corporation (TRMK)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NASDAQ
Market Cap: $2.76B
Last updated: Nov 17, 2026 at 11:06 AM ET
Trustmark Corporation (TRMK) Stock Forecast
Analysts expect Trustmark (TRMK) to earn $3.98 per share in the fiscal year ending Dec 31, 2026, on revenue of $831.73M. Of 6 analysts, 1 rates the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 17% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 1 | 16.7% |
| Hold | 5 | 83.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.0% and revenue estimates rise 8.4%.
- Fiscal year ending Dec 31, 2026
- $3.98
- EPS consensus, revenue $831.73M
- Fiscal year ending Dec 31, 2027
- $4.30
- EPS consensus, revenue $901.63M
- Next report
- Jan 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.98 | $3.92 to $4.05 | 5 | $831.73M | $786.40M to $848.50M | 4 |
| Dec 31, 2027 | $4.30 | $4.15 to $4.42 | 6 | $901.63M | $893.50M to $905.10M | 4 |
Quarterly Estimates
The EPS consensus falls from $1.06 for the quarter ending Dec 31, 2026 to $1.01 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.06 | $0.97 to $1.12 | 8 | $223.50M | $212.17M to $234.78M | 7 |
| Mar 31, 2027 | $1.01 | $0.92 to $1.05 | 6 | $218.38M | $213.30M to $221.20M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 4 upward and 7 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 3 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
| Quarter ending Mar 31, 2027 | 1 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.8% from $3.95.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $3.98 | $4.01 | $3.99 | $3.94 | $3.95 | +0.9% |
| Fiscal year ending Dec 31, 2027 | $4.30 | $4.33 | $4.29 | $4.11 | $4.11 | +4.5% |
| Quarter ending Mar 31, 2027 | $1.01 | $1.01 | $1.01 | $0.96 | $0.96 | +5.2% |
Frequently Asked Questions About TRMK
What is the TRMK stock forecast?
Consensus analyst estimates put Trustmark's EPS at $3.98 for the fiscal year ending Dec 31, 2026, on revenue of $831.73M. The consensus rating from 6 analysts is Hold.
How do analysts rate TRMK stock?
Of 6 analysts covering Trustmark, 0 rate it Strong Buy, 1 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from TRMK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $3.98, with estimates from $3.92 to $4.05 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.30, with estimates from $4.15 to $4.42 from 6 analysts.
What revenue do analysts expect from Trustmark next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $831.73M, with estimates from $786.40M to $848.50M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $901.63M, with estimates from $893.50M to $905.10M.
How many analysts cover TRMK?
6 analysts rate Trustmark stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
TRMK pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors